Lymphocyte Proliferation to Mitogens, Blood
Use
This test is useful for assessing T-cell function in patients undergoing immunosuppressive therapy, including those with solid-organ transplants. It helps evaluate patients suspected of having impaired cellular immunity, including those with primary immunodeficiencies such as DiGeorge syndrome and severe combined immunodeficiency, as well as secondary immunodeficiencies. The test is also valuable in assessing the recovery of T-cell function following bone marrow or hematopoietic stem cell transplantation.
Special Instructions
Not provided.
Limitations
Interpretation of results may be affected by factors such as patient use of steroids or immunosuppressive agents. Specimens older than 24 hours or containing gross hemolysis or lipemia might yield unreliable results. Timing and consistency in blood collection are crucial for accurate monitoring. The test does not provide absolute correlation between in vitro T-cell proliferation and clinical immunodeficiency.
Methodology
Cell-based / Cytometry (Flow Cytometry)
Biomarkers
CD19
ProteinCD3
ProteinCD45
Protein
LOINC Codes
- 69018-0 - Lymphocyte prolif mitogen pnl Bld FC
- 33193-4 - Viable cells NFr Bld
- 57741-1 - LPT OKT3 Bld-nRate
- 69038-8 - LPT PHA max/CD45 NFr Bld FC
- 69037-0 - LPT PW max/CD19 NFr Bld FC
- 69020-6 - LPT PW/CD3 NFr Bld FC
- 69019-8 - LPT PW/CD45 NFr Bld FC
- 69052-9 - Flow cytometry specialist review
- 48767-8 - Annotation comment Imp
Result Turnaround Time
8-11 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
20 mL
Minimum Volume
See Specimen Required
Container
Green top (sodium heparin)
Collection Instructions
Send whole blood specimen in the original tube. Do not aliquot.
Patient Preparation
For serial monitoring, it is recommended that specimen collection be performed at the same time of day.
Causes for Rejection
Gross hemolysis, Gross lipemia
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
